Favorable effect on postgraduate clinical practice of a drug-interaction exercise for undergraduate students

European Journal of Clinical Pharmacology

Volumn 62, Issue 7, 2006, Pages 571-576

  Tsuruoka, Shuichi ^a   Kawaguchi, Atsuhiro ^a   Harada, Kazuhiro ^a   Fujimura, Akio ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Drug interaction exercise; Postgraduate clinical practice; Undergraduate course

Indexed keywords

ACETYLSALICYLIC ACID; ALUMINUM; BICARBONATE; CISAPRIDE; CLARITHROMYCIN; CLOFIBRATE; CYCLOSPORIN; DIGOXIN; FUROSEMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; PROBENECID; QUINOLONE DERIVATIVE; RIFAMPICIN; TETRACYCLINE DERIVATIVE; VERAPAMIL; WARFARIN;

ADULT; ADVERSE DRUG REACTION; ARTICLE; CLINICAL PHARMACOLOGY; CLINICAL PRACTICE; DRUG CHOICE; FEMALE; FOOD DRUG INTERACTION; HEALTH CARE QUALITY; HUMAN; HUMAN EXPERIMENT; JAPAN; LEARNING; MALE; MEDICAL PRACTICE; MEDICAL STUDENT; NORMAL HUMAN; POSTGRADUATE EDUCATION; PRESCRIPTION; PRIORITY JOURNAL;

DRUG INTERACTIONS; DRUG PRESCRIPTIONS; EDUCATION, MEDICAL, UNDERGRADUATE; MEDICINE; PHARMACEUTICAL PREPARATIONS; PHARMACOLOGY, CLINICAL; PRESCRIPTIONS, DRUG; PROFESSIONAL PRACTICE; QUESTIONNAIRES; SPECIALIZATION; SPECIALTIES, MEDICAL; STUDENTS, MEDICAL;

EID: 33745727104     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-006-0142-y     Document Type: Article

References (14)

1. Stichtenoth DO, Frolich JC (2004) Pregraduate teaching clinical pharmacology in Germany. Eur J Clin Pharmacol 60:225-229
2. Orme M, Frolich J, Vrhovac B (2002) Towards a core curriculum in clinical pharmacology for undergraduate medical students in Europe. Eur J Clin Pharmacol 58:635-640
3. Vlahovic Palcevski V, Vitezic D, Zupan G, Simonic A (1998) Education in clinical pharmacology at the Rijeka School of Medicine, Croatia. Eur J Clin Pharmacol 54:685-689
4. Eroglu L, Uresin Y (2003) A model of pharmacology education: the experience of Istanbul medical faculty. J Clin Pharmacol 43:237-242
5. Smith CM (1997) Using student feedback on examination questions to promote fairness, item validity, and learning. J Clin Pharmacol 37:379-387
6. Michel MC, Bischoff A, Jakobs KH (2002) Comparison of problem-and lecture-based pharmacology teaching. Trends Pharmacol Sci 23:168-170
7. Whiting B, Holford NH, Begg EJ (2002) Clinical pharmacology: principles and practice of drug therapy in medical education. Br J Clin Pharmacol 54:1-2
8. Kawaguchi A, Sugimoto K, Ohmori M, Tsuruoka S, Harada K, Kitoh Y et al (2001) Furosemide-probenecid interaction as a laboratory exercise for undergraduate education in clinical pharmacology. Clin Pharmacol Ther 69:232-237
9. Quinn D, Day R (1997) Clinically important drug interactions. In: Speight T, Holford N (eds) Avery's drug treatment, 4th edn. Adis International, Auckland, pp 301-338
10. Guidance for Industry: drug metabolism/drug interactions in the drug development process. Studies in vitro. http://www.fda.gov/cder/guidance/clin3. pdf
11. Guidance for Industry: in vivo drug metabolism/drug interaction studies. Study design, data analysis, and recommendations for dosing and labeling. http://www.fda.gov/cder/guidance/2635fnl.pdf
12. Harada K, Fujimura A (2000) The need for improving information systems on drug interactions in Japan. Arch Intern Med 160:2063-2064
13. Honari J, Blair AD, Cutler RE (1977) Effects of probenecid on furosemide kinetics and natriuresis in man. Clin Pharmacol Ther 22:395-401
14. Pichette V, du Souich P (1996) Role of the kidneys in the metabolism of furosemide: its inhibition by probenecid. J Am Soc Nephrol 7:345-349